Malaria's next threat: drug-resistant parasites spread even after treatment
NCT ID NCT06347471
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at whether malaria parasites that are resistant to artemisinin drugs spread more easily after standard treatment. Researchers treated 160 people in Uganda who had malaria with either artemether-lumefantrine or dihydroartemisinin-piperaquine. They then used mosquito feeding tests to measure how many mosquitoes got infected before, during, and after treatment. The goal was to see if resistant parasites are more likely to be transmitted than non-resistant ones.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Artemether-lumefantrine (Coartem) and dihydroartemisinin-piperaquine (Eurartesim)
What this could lead to
If successful, this could help public health officials understand how drug-resistant malaria spreads and guide strategies to contain it.
What could go wrong
This is a small, completed observational study (160 participants) in one region, so results may not apply broadly. It measures transmission in the lab, not real-world spread.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALCIPARUM; MALARIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Ambrosoli Memorial Hospital
Kalongo, Agago District, Uganda
-
Patongo Health Facility IV
Patongo, Agago District, Uganda